1 results match your criteria: "Charité and Humboldt Universität zu Berlin[Affiliation]"
Therapeutic Phlebotomy in Patients with Grade 1 Hypertension: A Randomized-Controlled Trial.
J Integr Complement Med
June 2022
Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universitaät zu Berlin, Berlin, Germany.
Article Synopsis
- - The study aimed to explore how therapeutic phlebotomy (bloodletting) affects blood pressure in patients with grade 1 hypertension who are not on medication, comparing results between an intervention group and a control group over 8 weeks.
- - Results showed that while the intervention group had a slight decrease in mean arterial pressure (-1.12 mmHg), the control group experienced a slight increase (0.43 mmHg), suggesting minimal overall impact of phlebotomy on blood pressure.
- - Although some patients in the intervention group experienced mild adverse events like dizziness and anemia, there were no serious complications, indicating that the procedure is generally safe but may require more in-depth clinical trials for conclusive results.